Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice P Dutcher

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Blastic phase of chronic myelogenous leukemiaEvelyn L Morris, Janice P Dutcher
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
Renal cell carcinoma in patients with a personal or family history of hematologic malignanciesJanice P Dutcher, Peter H Wiernik
Journal of Investigative Medicine High Impact Case Reports|May 5, 2016
Pure Red Cell Aplasia Following Interleukin-2 TherapyJanice P Dutcher, Wen Fan, Peter H Wiernik
American Journal of Hematology|March 22, 2006
Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literatureAnuradha Kunthur, Peter H Wiernik, Janice P Dutcher
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
Families with both Hodgkin lymphoma and multiple myeloma in their pedigreesPeter H Wiernik, Dona Wickramasinghe, Janice P Dutcher
Oncology (Williston Park, N.Y.)|December 10, 2002
Managing toxicities of high-dose interleukin-2Rowena N Schwartz, Lori Stover, Janice P Dutcher
Oncology (Williston Park, N.Y.)|August 9, 2012
Integrating innovative therapeutic strategies into the management of renal cell carcinomaJanice P Dutcher, Waleed Fouad Mourad, Ronald D Ennis
Medical Oncology (Northwood, London, England)|January 1, 2010
Experience with sorafenib and the elderly patientJanice P Dutcher, Nizar Tannir, Joaquim Bellmunt, et al.
Leukemia Research|February 12, 2018
Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literatureMatthew P Blakley, Janice P Dutcher, Peter H Wiernik
Medical Oncology (Northwood, London, England)|June 21, 2005
Metastatic melanoma: is biochemotherapy the future?Doru T Alexandrescu, Janice P Dutcher, Peter H Wiernik
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Blastic phase of chronic myelogenous leukemiaEvelyn L Morris, Janice P Dutcher
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
Renal cell carcinoma in patients with a personal or family history of hematologic malignanciesJanice P Dutcher, Peter H Wiernik
Journal of Investigative Medicine High Impact Case Reports|May 5, 2016
Pure Red Cell Aplasia Following Interleukin-2 TherapyJanice P Dutcher, Wen Fan, Peter H Wiernik
American Journal of Hematology|March 22, 2006
Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literatureAnuradha Kunthur, Peter H Wiernik, Janice P Dutcher
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
Families with both Hodgkin lymphoma and multiple myeloma in their pedigreesPeter H Wiernik, Dona Wickramasinghe, Janice P Dutcher
Oncology (Williston Park, N.Y.)|December 10, 2002
Managing toxicities of high-dose interleukin-2Rowena N Schwartz, Lori Stover, Janice P Dutcher
Oncology (Williston Park, N.Y.)|August 9, 2012
Integrating innovative therapeutic strategies into the management of renal cell carcinomaJanice P Dutcher, Waleed Fouad Mourad, Ronald D Ennis
Medical Oncology (Northwood, London, England)|January 1, 2010
Experience with sorafenib and the elderly patientJanice P Dutcher, Nizar Tannir, Joaquim Bellmunt, et al.
Leukemia Research|February 12, 2018
Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literatureMatthew P Blakley, Janice P Dutcher, Peter H Wiernik
Medical Oncology (Northwood, London, England)|June 21, 2005
Metastatic melanoma: is biochemotherapy the future?Doru T Alexandrescu, Janice P Dutcher, Peter H Wiernik
Pageof 9